Novo Nordisk A/S (NVO)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap352.48B
EV352.48B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Valuation
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Price to Earnings
25.7
29.2
16.8
21.6
18.8
23.5
23.4
35.4
38.4
40.3
Price to Sales
7.6
9.4
5.7
7.4
6.5
7.5
7.8
12.0
12.0
13.1
Price to OCF
21.4
26.6
13.2
20.0
16.3
19.6
19.0
30.7
27.0
29.0
Price to FCF
24.8
32.0
15.9
25.3
22.6
25.8
33.0
35.5
33.2
36.5
Price to Book
16.9
21.7
14.1
16.5
14.0
15.9
15.6
23.9
25.5
30.9
EV to Sales
7.5
9.3
5.5
7.2
6.4
7.4
7.7
12.1
12.1
13.1
EV to EBITDA
17.7
21.6
12.1
15.5
13.8
15.7
16.3
25.2
26.1
29.6
EV to OCF
21.0
26.2
12.8
19.6
16.0
19.4
18.9
31.0
27.2
29.0
EV to FCF
24.3
31.5
15.5
24.8
22.1
25.5
32.9
35.8
33.4
36.7
Earnings Yield
3.9%
3.4%
5.9%
4.6%
5.3%
4.2%
4.3%
2.8%
2.6%
2.5%
FCF Yield
4.0%
3.1%
6.3%
3.9%
4.4%
3.9%
3.0%
2.8%
3.0%
2.7%
Market Cap
97,586.5
146,356.9
91,621.0
118,274.5
104,511.6
131,661.8
141,668.8
242,688.0
305,959.0
352,482.0